Characterization of CXCR4 expression in chondrosarcoma of bone

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 6, 2011, Pages 753-758

  Bai, Shuting ^a   Wang, Dezhi ^b   Klein, Michael J ^a   Siegal, Gene P ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE TUMOR; CHONDROSARCOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHONDROSARCOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, CXCR4; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79958859538     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410(6824):50-56. (Pubitemid 32225831)
2. Taichman RS, Cooper C, Keller ET, et al. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002;62(6):1832-1837. (Pubitemid 34408510)
3. Zeelenberg IS, Ruuls-Van Stalle L, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 2003; 63(13):3833-3839. (Pubitemid 36793074)
4. Phillips RJ, Burdick MD, Lutz M, et al. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med. 2003;167(12):1676-1686. (Pubitemid 36760683)
5. Koshiba T, Hosotani R, Miyamoto Y, et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res. 2000;6(9):3530-3535.
6. Scotton CJ, Wilson JL, Scott K, et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res. 2002; 62(20):5930-5938. (Pubitemid 35204756)
7. Hwang JH, Chung HK, Kim DW, et al. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells. J Clin Endocrinol Metab. 2003,88(1):408-416. (Pubitemid 36115196)
8. Percherancier Y, Berchiche YA, Slight I, et al. Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homoand heterodimers. J Biol Chem. 2005;280(11):9895-9903. (Pubitemid 40395837)
9. Vila-Coro AJ, Rodriguez-Frade JM, Martin De Ana A, Moreno-Ortíz MC, Martinez AC, Mellado M. The chemokine SDF-1 triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 1999; 13(13): 1699-1710. (Pubitemid 29473332)
10. Holland JD, Kochetkova M, Akekawatchai C, Dottore M, Lopez A, McColl SR. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in 289 breast cancer cells. Cancer Res. 2006;66(8):4117-4124.
11. Ganju RK, Brubaker SA, Meyer J, et al. The alpha-chemokine, stromal cell-derived factor-1 alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem. 1998; 273(36):23169-12175.
12. Zhao M, Discipio RG, Wimmer AG, Schraufstatter IU. Regulation of CXCR4-mediated nuclear translocation of extracellular signal-related kinases 1 and 2. Mol Pharmacol. 2006;69(1):66-75. (Pubitemid 43048894)
13. Busillo JM, Benovic JL. Regulation of CXCR4 signaling. Biochim Biophys Acta. 2007;1768(4):952-63. (Pubitemid 46452548)
14. Chinni SR, Sivalogan S, Dong Z, et al. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Prostate. 2006;66(1):32-48. (Pubitemid 43005947)
15. Libura J, Drukala J, Majka M, et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood. 2002;100(7):2597-2606.
16. Geminder H, Sagi-Assif O, Goldberg L, et al. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol. 2001; 167(8):4747-4757. (Pubitemid 32954357)
17. Barbero S, Bajetto A, Bonavia R, et al. Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann N Y Acad Sci. 2002;973:60-69. (Pubitemid 36124978)
18. Murakami T, Maki W, Cardones AR, et al. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 2002;62(24):7328-7334. (Pubitemid 36025256)
19. Clark JC, Dass CR, Choong PF. A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol. 2008;134(3):281-297. (Pubitemid 351170066)
20. Chow WA. Update on chondrosarcomas. Curr Opin Oncol. 2007; 19(4): 371-376. (Pubitemid 46883528)
21. Jang JH, Chung CP. Tenascin-C promotes cell survival by activation of Akt in human chondrosarcoma cell. Cancer Lett. 2005;229(1):101-105.
22. Akiyama H, Furukawa S, Wakisaka S, et al. Cartducin stimulates mesenchymal chondroprogenitor cell proliferation through both extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways. FEBS J. 2006;273(10):2257-2263.
23. Papachristou DJ, Papachristou GI, Papaefthimiou OA, et al. The MAPK-AP-1/-Runx2 signalling axes are implicated in chondrosarcoma pathobiology either independently or via up-regulation of VEGF. Histopathology. 2005;47(6): 565-574. (Pubitemid 41775178)
24. Perissinotto E, Cavalloni G, Leone F, et al. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression. Clin Cancer Res. 2005;11(2, pt 1):490-497. (Pubitemid 40116871)
25. Ramachandran K, Sasidharan K, Gangadharan V, et al. Ossified lymph node metastases from osteosarcoma. Indian J Radiol Imaging. 1999;9(2):89-90. (Pubitemid 29371967)
26. Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer. 1977;40(2):818-831. (Pubitemid 8177905)
27. Zushi Y, Noguchi K, Hashitani S, et al. Relations among expression of CXCR4, histological patterns, and metastatic potential in adenoid cystic carcinoma of the head and neck. Int J Oncol. 2008;33(6):1133-1139.
28. Cheng Z, Zhou S, Wang X, et al. Characterization and application of two novel monoclonal antibodies against human CXCR4: cell proliferation and migration regulation for glioma cell line in vitro by CXCR4/SDF1a signal. Hybridoma. 2009;28:33-41.
29. Gonzalez H, Leiva A, Tobar H, et al. Altered chemokine receptor expression in papillary thyroid cancer. Thyroid. 2009;19(9):957-965.
30. Salmaggi A, Maderna E, Calatozzolo C, et al. CXCL12, CXCR4 and CXCR7 expression in brain metastases. Cancer Biol Ther. 2009;8(17):1608-1614.
31. Laverdiere C, Hoang BH, Yang R, et al. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res. 2005;11(7):2561-2567. (Pubitemid 40569454)
32. Allen S, Crown S, Handel T. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol. 2007;25:787-820. (Pubitemid 46697924)
33. Neel N, Schutyser E, Sai J, et al. Chemokine receptor internalization and intracellular trafficking. Cytokine Growth Factor Rev. 2005;16(6):637-658. (Pubitemid 41505521)
34. New DC, Wong YH. CC chemokine receptor-coupled signalling pathway. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003;35(9):779-788.
35. Zimmermann N, Conkright J, Rothenberg ME. CC chemokine receptor-3 undergoes prolonged ligand-induced internalizaion. J Biol Chem. 1999;274(18): 12611-12618.
36. Lai TH, Fong YC, Fu WM, Yang RS, Tang CH. Stromal cell-derived factor-1 increase αvβ3 integrin expression and invasion in human chondrosarcoma cells. J Cell Physiol. 2009;218(2):334-342.
37. Sun X, Wei L, Chen Q, Terek RM. CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMPI expression. Mol Cancer. 2010;9:17-28.